- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04765072
Expanding Rural Health Cancer Control Capacity
November 12, 2024 updated by: Debra Friedman
Expanding Rural Health Cancer Control Capacity: Focus on Cancer Survivorship
Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties.
The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
Study Aims:
- Pilot test the implementation of guideline-based survivorship care planning in a rural setting using patient navigation plus telehealth among underserved rural cancer survivors. Investigators will collect feasibility data on patient recruitment rates and the ability to measure clinical effectiveness outcomes using the electronic health record and patient reports (survivor adherence to recommended disease surveillance, health assessment and cancer prevention/early detection practices).
- Identify the facilitators and barriers to future larger scale implementation of guideline-based survivorship care planning in rural settings to optimize the implementation strategies. Through a mixed methods approach, investigators will address implementation research questions focused on "real world" implementation of the guideline-based intervention in rural areas, including barriers/facilitators and translation to other rural settings. This will allow us to optimize the implementation strategies that will be further evaluated in the future large-scale implementation trial
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mississippi
-
Columbus, Mississippi, United States, 39705
- Baptist Cancer Center- Golden Triangle Columbus
-
Oxford, Mississippi, United States, 38655
- Baptist Cancer Center - North Mississippi
-
-
Tennessee
-
Bartlett, Tennessee, United States, 38133
- Baptist Cancer Center- Bartlett
-
Nashville, Tennessee, United States, 37232
- Vanderbilt-Ingram Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Cancer patient at least 18 years of age at time of cancer therapy
- English-speaking with the ability to provide informed consent
- Received treatment for Stage 0 - III cancer with curative intent
- Completed cancer therapy within the previous 12 months (i.e., 12 months prior to consenting) and in complete remission
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Survivorship care
Participants in rural areas will receive a telehealth (providing health-related services through electronic communication technologies) survivorship care plan in combination with assistance from a patient navigator.
|
Patient navigator assistance for navigating the healthcare system and locating and utilizing beneficial resources
Individualized survivorship care plan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of improvement in adherence to survivorship plan (Survivorship Care Planning Experience Satisfaction Survey (1-5 Excellent - Poor)
Time Frame: Approximately 12 months
|
Approximately 12 months
|
|
Measure effectiveness of Telehealth on survivorship care
Time Frame: Approximately 12 months
|
Approximately 12 months
|
|
Estimate the facilitators to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Time Frame: Approximately 1 year
|
Approximately 1 year
|
|
Estimate the barriers to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Time Frame: Approximately 1 year
|
Approximately 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Debra Friedman, MD, Vanderbilt-Ingram Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 26, 2021
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2029
Study Registration Dates
First Submitted
February 12, 2021
First Submitted That Met QC Criteria
February 17, 2021
First Posted (Actual)
February 21, 2021
Study Record Updates
Last Update Posted (Actual)
November 15, 2024
Last Update Submitted That Met QC Criteria
November 12, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- VICC PED 2019
- 3P30CA068485-24S2 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
Clinical Trials on Survivorship Patient Navigation Intervention
-
Boston Medical CenterBoston University; Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center and other collaboratorsCompletedCancer, BreastUnited States
-
University of Colorado, DenverDenver Health and Hospital Authority; Rocky Mountain Human Services; El Grupo...Completed
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedSexual Behavior | Substance AbuseUnited States
-
Milton S. Hershey Medical CenterNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Columbia UniversitySusan G. Komen Breast Cancer FoundationCompleted
-
University College CorkSidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Cork University... and other collaboratorsCompletedCervical Cancer | Breast Cancer | Endometrial Cancer | SurvivorshipIreland
-
University of UtahUniversity of PittsburghCompletedPregnancy Related | Pregnancy, High Risk | Opioid-Related DisordersUnited States
-
Massachusetts General HospitalAmerican Cancer Society, Inc.CompletedTobacco Use | Lung Cancer | HomelessnessUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Global Cancer InstituteCompleted
-
Massachusetts General HospitalCompleted